Caribou Biosciences, Inc. - Common Stock (CRBU)

CUSIP: 142038108

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
+3,229,592
Put/Call ratio
15%
SEC-reported price per share
$5.43
Number of holders
116
Value change
+$14,914,954
Number of buys
61
Open additional details 1 more signal available
Number of sells
47
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
99,672,278

Security key

142038108

Report period

Q2 2022

Institutions

116

Top holders

10

Ownership snapshot

Top reported holders of CRBU - Caribou Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PFM Health Sciences, LP
Disclosed value leader
PFM Health Sciences, LP
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F 3/4/5 Highest disclosed value: $40,122,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PFM Health Sciences, LP has the largest disclosed position value at $40.12M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PFM Health Sciences, LP's linked filing trail.
Disclosed position value Top 5
PFM Health Sciences, LP $40.12M
BlackRock Finance, Inc. $30.47M
Avidity Partners Management LP $25.88M
PICTET ASSET MANAGEMENT SA $24.64M
FARALLON CAPITAL MANAGEMENT, L.L.C. $24.39M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PFM Health Sciences, LP
13F
Company
13F
—
denominator unverified
$40,122,000
4,370,545 shares
— 31 Mar 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$30,470,000
3,319,182 shares
— 31 Mar 2022
Avidity Partners Management LP
13F
Company
13F
—
denominator unverified
$25,879,000
2,819,067 shares
— 31 Mar 2022
PICTET ASSET MANAGEMENT SA
13F
Company
13F
—
denominator unverified
$24,644,000
2,684,548 shares
— 31 Mar 2022
FARALLON CAPITAL MANAGEMENT, L.L.C.
13F
Company
13F
—
denominator unverified
$24,392,000
2,657,052 shares
— 31 Mar 2022
FMR LLC
13F 3/4/5
Company · Other*
—
denominator unverified
$18,479,000
2,013,033 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
116
Shares
37,333,019
Rows available
116
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
103
Q2 2022 holders
116
Holder diff
13
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .